The prognostic value of residual volume/total lung capacity in patients with chronic obstructive pulmonary disease

Journal of Korean Medical Science

Volumn 30, Issue 10, 2015, Pages 1459-1465

  Shin, Tae Rim ^a   Oh, Yeon Mok ^b   Park, Joo Hun ^c   Lee, Keu Sung ^c   Oh, Sunghee ^c   Kang, Dae Ryoung ^c   Sheen, Seungsoo ^c   Seo, Joon Beom ^b   Yoo, Kwang Ha ^d   Lee, Ji Hyun ^e   Kim, Tae Hyung ^f   Lim, Seong Yong ^g   Yoon, Ho Il ^h   Rhee, Chin Kook ⁱ   Choe, Kang Hyeon ^j   Lee, Jae Seung ^b   Lee, Sang Do ^b  

^a Hallym University Medical Center   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Ajou University School of Medicine   (South Korea)

^d Konkuk University School of Medicine   (South Korea)

^e CHA University   (South Korea)

^f Hanyang University Guri Hospital   (South Korea)

^g Sungkyunkwan University School of Medicine   (South Korea)

^h Seoul National University Bundang Hospital   (South Korea)

ⁱ The Catholic University of Korea   (South Korea)

^j Chungbuk National University College of Medicine   (South Korea)

more..

Author keywords

COPD; Hyperinflation; Residual volume; Survival; Total lung capacity

Indexed keywords

AGED; CLINICAL TRIAL; DYSPNEA; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; HUMAN; LUNG; LUNG FUNCTION TEST; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; QUESTIONNAIRE; RESIDUAL VOLUME; SOUTH KOREA; TOTAL LUNG CAPACITY; VITAL CAPACITY; WALKING;

AGED; DYSPNEA; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY FLOW RATES; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; MALE; MIDDLE AGED; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; REPUBLIC OF KOREA; RESIDUAL VOLUME; RESPIRATORY FUNCTION TESTS; SURVEYS AND QUESTIONNAIRES; TOTAL LUNG CAPACITY; VITAL CAPACITY; WALKING;

EID: 84945968453     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2015.30.10.1459     Document Type: Article

References (29)

1. Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187: 347-65.
2. Ferguson GT. Why does the lung hyperinflate? Proc Am Thorac Soc 2006; 3: 176-9.
3. Casanova C, Cote C, de Torres JP, Aguirre-Jaime A, Marin JM, Pinto-Plata V, Celli BR. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171: 591-7.
4. Martinez FJ, de Oca MM, Whyte RI, Stetz J, Gay SE, Celli BR. Lung-volume reduction improves dyspnea, dynamic hyperinflation, and respiratory muscle function. Am J Respir Crit Care Med 1997; 155: 1984-90.
5. Marchand E, Gayan-Ramirez G, De Leyn P, Decramer M. Physiological basis of improvement after lung volume reduction surgery for severe emphysema: where are we? Eur Respir J 1999; 13: 686-96.
6. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002; 121: 1434-40.
7. Budweiser S, Harlacher M, Pfeifer M, Jörres RA. Co-morbidities and hyperinflation are independent risk factors of all-cause mortality in very severe COPD. COPD 2014; 11: 388-400.
8. Slebos DJ, Klooster K, Ernst A, Herth FJ, Kerstjens HA. Bronchoscopic lung volume reduction coil treatment of patients with severe heterogeneous emphysema. Chest 2012; 142: 574-82.
9. Lahaije AJ, van Helvoort HA, Dekhuijzen PN, Vercoulen JH, Heijdra YF. Resting and ADL-induced dynamic hyperinflation explain physical inactivity in COPD better than FEV1. Respir Med 2013; 107: 834-40.
10. Krieger BP. Hyperinflation and intrinsic positive end-expiratory pressure: less room to breathe. Respiration 2009; 77: 344-50.
11. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 1995; 152: 1107-36.
12. Albuquerque AL, Nery LE, Villaça DS, Machado TY, Oliveira CC, Paes AT, Neder JA. Inspiratory fraction and exercise impairment in COPD patients GOLD stages II-III. Eur Respir J 2006; 28: 939-44.
13. Wouters EF, Postma DS, Fokkens B, Hop WC, Prins J, Kuipers AF, Pasma HR, Hensing CA, Creutzberg EC; COSMIC (COPD and Seretide: a Multi-Center Intervention and Characterization) Study Group. Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial. Thorax 2005; 60: 480-7.
14. Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet 2007; 370: 786-96.
15. Gevenois PA, de Maertelaer V, De Vuyst P, Zanen J, Yernault JC. Comparison of computed density and macroscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 1995; 152: 653-7.
16. Wood SA, Zerhouni EA, Hoford JD, Hoffman EA, Mitzner W. Measurement of three-dimensional lung tree structures by using computed tomography. J Appl Physiol 1995; 79: 1687-97.
17. Lee YK, Oh YM, Lee JH, Kim EK, Lee JH, Kim N, Seo JB, Lee SD; KOLD Study Group. Quantitative assessment of emphysema, air trapping, and airway thickening on computed tomography. Lung 2008; 186: 157-65.
18. Nakano Y, Muro S, Sakai H, Hirai T, Chin K, Tsukino M, Nishimura K, Itoh H, Paré PD, Hogg JC, et al. Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. Am J Respir Crit Care Med 2000; 162: 1102-8.
19. O'Donnell DE, Revill SM, Webb KA. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 770-7.
20. Tantucci C, Duguet A, Similowski T, Zelter M, Derenne JP, Milic-Emili J. Effect of salbutamol on dynamic hyperinflation in chronic obstructive pulmonary disease patients. Eur Respir J 1998; 12: 799-804.
21. Marin JM, Carrizo SJ, Gascon M, Sanchez A, Gallego B, Celli BR. Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1395-9.
22. Diaz O, Villafranca C, Ghezzo H, Borzone G, Leiva A, Milic-Emil J, Lisboa C. Role of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest. Eur Respir J 2000; 16: 269-75.
23. O'Donnell DE, Webb KA. Exertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflation. Am Rev Respir Dis 1993; 148: 1351-7.
24. Nishimura K, Yasui M, Nishimura T, Oga T. Airflow limitation or static hyperinflation: which is more closely related to dyspnea with activities of daily living in patients with COPD? Respir Res 2011; 12: 135.
25. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease. Revised 2011. Available at http://www.goldcopd. org/uploads/users/files/GOLD_Report_2011_Feb21.pdf [accessed on 15 July 2015].
26. Domingo-Salvany A, Lamarca R, Ferrer M, Garcia-Aymerich J, Alonso J, Félez M, Khalaf A, Marrades RM, Monsó E, Serra-Batlles J, et al. Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166: 680-5.
27. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 1005-12.
28. Hurst JR, Vestbo J, Anzueto A, Locantore N, Müllerova H, Tal-Singer R, Miller B, Lomas DA, Agusti A, Macnee W, et al.; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010; 363: 1128-38.
29. O'Donnell DE. Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006; 3: 180-4.